WHO statement on hormonal contraception and bone health

d'Arcangues, Catherine

doi:10.1016/j.contraception.2006.01.002

Cited by 110Reproductive Health and ContraceptionBone health and osteoporosis researchMenopause: Health Impacts and Treatments

WHO statement on hormonal contraception and bone health

d'Arcangues, Catherine·2006·Contraception

DOI 10.1016/j.contraception.2006.01.002

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/j.contraception.2006.01.002

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

According to ACOG and WHO recommendations, the benefits of DMPA use surpass the risks.
“according to the American College of Obstetricians and Gynecologists (ACOG) [48] and WHO recommendations [72] the benefits of DMPA use surpasses the risks.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [72]

Sorted by citations

Contraception and health
Cleland, J., Conde‐Agudelo, A., Peterson, H. B., Ross, J. A., & TSUI, A. O. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60609-6 · Cited by 827 · see citing works
Risks of contraception and pregnancy in heart disease
Thorne, S., MacGregor, A., & Nelson-Piercy, C. (2006) · Heart · doi:10.1136/hrt.2006.095240 · Cited by 456 · see citing works
A brief history of FRAX
Kanis, J. А., Johansson, H., Harvey, N. C., & McCloskey, E. V. (2018) · Archives of Osteoporosis · doi:10.1007/s11657-018-0510-0 · Cited by 259 · see citing works
Medication-induced osteoporosis: screening and treatment strategies
Panday, K., Gona, A., & Humphrey, M. B. (2014) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x14546350 · Cited by 201 · see citing works
Steroidal contraceptives: effect on bone fractures in women
Lopez, L. M., Grimes, D. A., Schulz, K. F., Curtis, K. M., & Chen, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006033.pub5 · Cited by 168 · see citing works
Bone density recovery after depot medroxyprogesterone acetate injectable contraception use
Kaunitz, A. M., Arias, R., & McClung, M. R. (2008) · Contraception · doi:10.1016/j.contraception.2007.10.005 · Cited by 148 · see citing works
Depot Medroxyprogesterone Acetate and Bone Mineral Density in Adolescents—The Black Box Warning: A Position Paper of the Society for Adolescent Medicine
Cromer, B. A., Scholes, D., Berenson, A. B., Cundy, T., Clark, M. K., & Kaunitz, A. M. (2006) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2006.03.011 · Cited by 143 · see citing works
Adolescent Bone Health
Loud, K. J., & Gordon, C. M. (2006) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.160.10.1026 · Cited by 108 · see citing works
Hormonal contraception and bone metabolism: a systematic review
Nappi, C., Bifulco, G., Tommaselli, G. A., Gargano, V., & Carlo, C. D. (2012) · Contraception · doi:10.1016/j.contraception.2012.04.009 · Cited by 107 · see citing works
Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea
Bahamondes, L. G., Petta, C. A., Fernandes, A. M. D. S., & MONTEIRO, I. M. U. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.008 · Cited by 105 · see citing works
“Because of the profound hypoestrogenism provoked by these drugs, bone mineral density is the principal concern [6] that limits their use to 6 months, although longer treatment with add-back hormone therapy is possible.”
Background
Steroidal contraceptives and bone fractures in women: evidence from observational studies
Lopez, L. M., Chen, M., Long, S., Curtis, K. M., & Helmerhorst, F. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009849.pub3 · Cited by 102 · see citing works
Progestin-only contraception: Injectables and implants
Jacobstein, R., & Polis, C. B. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.05.003 · Cited by 90 · see citing works
Update on hormonal contraception and bone density
Isley, M. M., & Kaunitz, A. M. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9180-6 · Cited by 67 · see citing works
A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants
Bahamondes, L., Monteiro-Dantas, C., Espejo-Arce, X., dos Santos Fernandes, A. M., Lui-Filho, J. F., Perrotti, M., & Petta, C. A. (2006) · Human Reproduction · doi:10.1093/humrep/dei358 · Cited by 66 · see citing works
Oral and depot progestin therapy for endometriosis: towards a personalized medicine
Buggio, L., Somigliana, E., Barbara, G., Frattaruolo, M. P., & Vercellini, P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1381086 · Cited by 58 · see citing works
“the American College of Obstetricians and Gynecologists (ACOG) [48] and WHO recommendations [72], the benefits of DMPA use surpasses the risks.”
Background
Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling
Fisher, W. A., & Black, A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060851 · Cited by 55 · see citing works
Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant
Modesto, W., Dal’Ava, N., MONTEIRO, I. M. U., & Bahamondes, L. G. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3784-0 · Cited by 55 · see citing works
Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system
Bahamondes, M. V., MONTEIRO, I. M. U., Castro, S., Espejo‐Arce, X., & Bahamondes, L. G. (2010) · Human Reproduction · doi:10.1093/humrep/deq043 · Cited by 52 · see citing works
The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health
Guilbert, É., Brown, J. P., Kaunitz, A. M., Wagner, M.-S., Bérubé, J., Charbonneau, L., Francoeur, D., Gilbert, A., Gilbert, F., Roy, G., et al. (2009) · Contraception · doi:10.1016/j.contraception.2008.10.016 · Cited by 50 · see citing works
Helping Women Choose Appropriate Hormonal Contraception: Update on Risks, Benefits, and Indications
Spencer, A. L., Bonnema, R. A., & McNamara, M. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.016 · Cited by 46 · see citing works
Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis
Shen, L., Ling, L., Jianhong, Z., Jiang, X., & Lihui, W. (2013) · Journal of International Medical Research · doi:10.1177/0300060513479865 · Cited by 46 · see citing works
“GnRH-a are widely used to reduce endometriosis-related pain but are associated with a reduction in bone-mineral density, which limits their use to a period of 6 months.(7) Other side-effects of these agents include hot flushes, insomnia, vaginal dryness and emotional lability.”
Sexual and reproductive health considerations among transgender and gender-expansive youth
Mehringer, J. E., & Dowshen, N. (2019) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2019.100684 · Cited by 40 · see citing works
Medical Barriers to Effective Contraception
Leeman, L. M. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.01.003 · Cited by 41 · see citing works
Long-acting contraceptives in adolescents
Tolaymat, L. L., & Kaunitz, A. M. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282ef1cd2 · Cited by 40 · see citing works
Novel drug delivery methods for improving efficacy of endometriosis treatments
Garzon, S., Laganà, A. S., Barra, F., Casarin, J., Cromi, A., Raffaelli, R., Uccella, S., Franchi, M. P., Ghezzi, F., & Ferrero, S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1829589 · Cited by 42 · see citing works
Contraception choices in women with underlying medical conditions.
Bonnema, R. A., McNamara, M., & Spencer, A. L. (2010) · PubMed · Cited by 38 · see citing works
Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
Kailasam, C. (2008) · Patient Preference and Adherence · doi:10.2147/ppa.s3464 · Cited by 39 · see citing works
“Medical treatments that are based on the reduction of lesions or on ovarian estrogen suppression, cause profound hypoestrogenism inducing a decrease in bone mineral density and hence treatment is limited 6 months (d’Arcangues 2006), although longer treatment with add-back hormone therapy is possible.”
Background
A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
Monteiro-Dantas, C., Espejo‐Arce, X., Lui-Filho, J. F., Fernandes, A. M. D. S., MONTEIRO, I. M. U., & Bahamondes, L. G. (2007) · Reproductive Health · doi:10.1186/1742-4755-4-11 · Cited by 38 · see citing works
“Although a recommendation issued by the World Health Organization (WHO) also established some restrictions to the use of DMPA, principally in adolescents and in women in the menopausal transition [ 11 ], it has also established that the data on levonorgestrel (LNG)-releasing implants suggest no adverse effect on BMD a…”
Background
The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age
Gai, L., Zhang, J., Zhang, H., Gai, P., Zhou, L., & Liu, Y. (2010) · Contraception · doi:10.1016/j.contraception.2010.07.027 · Cited by 35 · see citing works
Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate
Modesto, W., Bahamondes, M. V., & Bahamondes, L. (2015) · Journal of Women's Health · doi:10.1089/jwh.2014.5077 · Cited by 36 · see citing works
Bone status after cessation of use of injectable progestin contraceptives
Rosenberg, L. A., Zhang, Y., Constant, D., Cooper, D. D., Kalla, A. A., Micklesfield, L. K., & Hoffman, M. N. (2007) · Contraception · doi:10.1016/j.contraception.2007.08.010 · Cited by 35 · see citing works
Steroidal contraceptives: effect on bone fractures in women
Lopez, L. M., Grimes, D. A., Schulz, K. F., & Curtis, K. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006033.pub4 · Cited by 33 · see citing works
RETIRED: Canadian Contraception Consensus—Update on Depot Medroxyprogesterone Acetate (DMPA)
Black, A., Dunn, S., Guilbert, É., Léger, F., Mirosh, M., Reid, R. L., Josse, R., Lalonde, A. B., & Senikas, V. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32125-9 · Cited by 32 · see citing works
Steroidal contraceptives and bone fractures in women: evidence from observational studies
Lopez, L. M., Chen, M., Mullins, S., Curtis, K. M., & Helmerhorst, F. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009849.pub2 · Cited by 32 · see citing works
Approach to the Adolescent Requesting Contraception
Gordon, C. M., & Pitts, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1780 · Cited by 29 · see citing works
Removing the black box warning for depot medroxyprogesterone acetate
Kaunitz, A. M., & Grimes, D. A. (2011) · Contraception · doi:10.1016/j.contraception.2011.01.009 · Cited by 27 · see citing works
Adolescent Contraception: Review and Guidance for Pediatric Clinicians
Hartman, L. B., Monasterio, E., & Hwang, L. Y. (2012) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2012.05.001 · Cited by 28 · see citing works
Noncontraceptive Uses of Hormonal Contraception
King, J. (2011) · Journal of Midwifery & Women s Health · doi:10.1111/j.1542-2011.2011.00118.x · Cited by 26 · see citing works
Considerations for the use of progestin‐only contraceptives
Freeman, S. B., & SHULMAN, L. P. (2010) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2009.00473.x · Cited by 24 · see citing works
Controversies in contraception
Pitts, S., & Emans, S. J. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328305e13f · Cited by 23 · see citing works
Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: a meta-analysis
Song, S. Y., Park, M., Lee, G. W., Lee, K. H., Chang, H. K., Kwak, S. M., & Yoo, H. J. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.10.014 · Cited by 24 · see citing works
Management of menstrual problems in adolescents with learning and physical disabilities
Jeffery, E., Kayani, S. I., & Garden, A. (2013) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12008 · Cited by 23 · see citing works
Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate
Viola, A. S., Castro, S., Marchi, N. M., Bahamondes, M. V., Viola, C. F. M., & Bahamondes, L. G. (2010) · Contraception · doi:10.1016/j.contraception.2010.11.007 · Cited by 19 · see citing works
Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians
Paschall, S., & Kaunitz, A. M. (2008) · Contraception · doi:10.1016/j.contraception.2008.07.022 · Cited by 20 · see citing works
Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception
Beksinska, M. E., Kleinschmidt, I., Smit, J. A., & Farley, T. M. M. (2007) · Contraception · doi:10.1016/j.contraception.2007.02.001 · Cited by 21 · see citing works
Progestin-only contraception prevents bone loss in postpartum breastfeeding women
Costa, M. L., Cecatti, J. G., Krupa, F., Rehder, P. M., Sousa, M. H., & Costa‐Paiva, L. (2011) · Contraception · doi:10.1016/j.contraception.2011.08.015 · Cited by 19 · see citing works
“The clinical implications of this finding are still not clear since the declines in BMD associated with lactation do not appear to have long-term skeletal health consequences; however, it does influence family planning and should strengthen data on safety of DMPA use, preventing unwanted pregnancies [10].”
Background
The Cochrane Fertility Regulation Group: synthesizing the best evidence about family planning
Helmerhorst, F. M., Belfield, T., Kulier, R., Maitra, N., O'Brien, P., & Grimes, D. A. (2006) · Contraception · doi:10.1016/j.contraception.2006.04.004 · Cited by 17 · see citing works
Beyond a prescription: strategies for improving contraceptive care
Singh, R. H., Frost, J. J., Jordan, B., et al. (2008) · Contraception · doi:10.1016/j.contraception.2008.09.015 · Cited by 17 · see citing works
Update in Adolescent Contraception
Lara‐Torre, E. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2008.12.003 · Cited by 15 · see citing works
Home-based administration of Sayana® Press: review and assessment of needs in low-resource settings
Keith, B., Wood, S., Tifft, S., & Hutchings, J. E. (2014) · Contraception · doi:10.1016/j.contraception.2014.03.003 · Cited by 16 · see citing works
Steroidal contraceptives: effect on bone fractures in women
Lopez, L. M., Grimes, D. A., Schulz, K. F., & Curtis, K. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006033.pub3 · Cited by 15 · see citing works
Contraception and the obese woman
Reifsnider, E., Mendias, N., Davila, Y., & Babendure, J. B. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1111/1745-7599.12011 · Cited by 14 · see citing works
Use of hormonal contraception in adolescents: skeletal health issues
Tolaymat, L. L., & Kaunitz, A. M. (2009) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32832c9cc6 · Cited by 14 · see citing works
Patient-Centered Contraceptive Counseling
Yecies, E. B., & Borrero, S. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-50695-7_4 · Cited by 13 · see citing works
Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate
Sanches, L., Marchi, N. M., Castro, S., Juliato, C. T., Villarroel, M., & Bahamondes, L. G. (2008) · Contraception · doi:10.1016/j.contraception.2008.07.013 · Cited by 12 · see citing works
A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate
Viola, A. S., Castro, S., Bahamondes, M. V., Fernandes, A. M. D. S., Viola, C. F. M., & Bahamondes, L. G. (2011) · Contraception · doi:10.1016/j.contraception.2011.06.012 · Cited by 12 · see citing works
“use of DMPA by women in menopausal transition or in adolescence [7].”
BackgroundMethodInfluential
Depot Medroxyprogesterone Acetate Use and Blood Lead Levels in a Cohort of Young Women
Upson, K., Harmon, Q. E., Heffron, R. A., Hall, J. E., Wise, L. A., Wegienka, G., Tokar, E. J., & Baird, D. D. (2020) · Environmental Health Perspectives · doi:10.1289/ehp7017 · Cited by 10 · see citing works
“These data would have provided insight into whether the release of lead from bone into blood mirrors the pattern of bone loss observed with DMPA use, with loss being greatest in the first 2 y after DMPA initiation and then continuing at a slower rate with longer use (d’Arcangues 2006).”
Background
Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives
Bahamondes, L. G., Juliato, C. T., Villarreal, M., Lima, B. S. S., Simões, J. A., & Fernandes, A. M. D. S. (2006) · Contraception · doi:10.1016/j.contraception.2006.03.019 · Cited by 10 · see citing works
Third-generation oral contraceptives: future implications of current use
Ouzounian, S., Verstraete, L., & Chabbert‐Buffet, N. (2008) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.3.2.189 · Cited by 9 · see citing works
Comparative Performance of a Combined Injectable Contraceptive (50 mg Norethisterone Enanthate Plus 5mg Estradiol Valerate) and a Combined Oral Contraceptive (0.15 mg Levonorgestrel plus 0.03 mg Ethinyl Estradiol) in Adolescents
Molina, R., Sandoval, J. Z., Montero, A. V., et al. (2009) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2008.07.010 · Cited by 9 · see citing works
Reproductive Health Care of Adolescent Women
Hayon, R., Dalby, J., Paddock, E., Combs, M., & Schrager, S. (2013) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2013.04.120283 · Cited by 8 · see citing works
Effects of oestrogen deficiency on bone mineralisation in girls during "adolescent crisis".
Sowińska‍-Przepiera, E., Andrysiak‍-Mamos, E., Jarząbek‐Bielecka, G., Friebe, Z., & Syrenicz, A. (2011) · PubMed · Cited by 7 · see citing works
Long-term effects of progestins on bone quality and fractures
Thijssen, J. H. H. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701584931 · Cited by 8 · see citing works
Association between depot medroxyprogesterone acetate (DMPA), physical activity and bone health
Babatunde, O. O., & Forsyth, J. J. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0497-y · Cited by 8 · see citing works
“Regulating bodies [2, 14] have therefore advocated no restrictions to DMPA use, and have sug-”
Background
DMPA: battered and bruised but still needed and used in the USA
Nelson, A. L. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.10.60 · Cited by 5 · see citing works
Reflections on Depo Provera: Contributions to Improving Drug Regulation in Canada
Shea, L. (2007) · Cited by 6 · see citing works
Combined Oral Contraceptive in Adolescent and Young Adult Women: Current Evidence and Future Perspectives
Rapisarda, A. M. C., Brescia, R., Sapia, F., Valenti, G., Sarpietro, G., Gregorio, L. M. D., Gatta, A. N. D., Rosa, V. L. L., Sergiampietri, C., Corte, L. D., et al. (2018) · Current Women s Health Reviews · doi:10.2174/1573404814666180914162053 · Cited by 5 · see citing works
Family planning in adolescents
Ganti, A. K., & Hillard, P. J. A. (2019) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000577 · Cited by 5 · see citing works
Contraception today and family planning: a comprehensive review and position statement on the ethical, medical, and social dimensions of modern contraception
Genazzani, A. R., Fidecicchi, T., Arduini, D., Benagiano, G., Birkhaeuser, M. H., Schenker, J. G., Strauss, J. F., Awad, D. V., Arnal, J., Bahamondes, L. G., et al. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2543423 · Cited by 5 · see citing works
“The WHO stated that there should be no restriction on the use of POPs and on duration of use [188].”
Effect of Two Kinds of Different Combined Oral Contraceptives Used on Bone Mineral Density in Women of Reproductive Age
Rui-jian, L. I. U., Gai, L., Jia, Y., Gai, P., & Yu, X. (2011) · Chin J Reprod Contracep · doi:10.1016/s1001-7844(12)60010-8 · Cited by 4 · see citing works
Female genital mutilation and contraceptive use: findings from the 2014 Egypt demographic health survey
Masho, S. W., Orekoya, O., Lowery, E. P., & Wallenborn, J. T. (2020) · International Journal of Public Health · doi:10.1007/s00038-020-01452-w · Cited by 3 · see citing works
Bone loss associated with long-term use of depot medroxyprogesterone acetate.
Lo, S. S. T., & Fan, S. Y. (2005) · PubMed · Cited by 4 · see citing works
Hormonal contraception and bone mineral density
Beksinska, M. E., & Smit, J. A. (2011) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.11.19 · Cited by 4 · see citing works
Hormonal Contraception and Bone Mineral Density
Zander, K. D. (2007) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000282070.22555.ca · Cited by 3 · see citing works
Einfluss von hormonellen Kontrazeptiva auf das Größenwachstum und den Knochenbau von 12-14-jährigen Mädchen: Stellungnahme der DGGEF
Rabe, T., Bettendorf, M., Friedmann-Bette, B., Hadji, P., & Strowitzki, T. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3 · see citing works
Bone mineral density in women of a low socioeconomic level using DMPA for contraception in rural Upper Egypt
Hussein, M., Mahran, D. G., Farouk, O. A., El‐Assal, M. A., Fathallah, M. M., & Romih, M. S. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.01.023 · Cited by 2 · see citing works
Progestin-Only Contraception and Bone Health
Isley, M. M. (2017) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-017-0201-7 · Cited by 2 · see citing works
Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study
Bjelland, E. K., Owe, K. M., Nordeng, H., Engdahl, B., Kristiansson, P., Vangen, S., & Eberhard‐Gran, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184071 · Cited by 2 · see citing works
Bone Health and Hormonal Contraception
Dragoman, M. V., Kaunitz, A. M., & McClung, M. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1233-9_16 · Cited by 2 · see citing works
Does the use of hormonal contraceptives affect bone mineral density?
Bahamondes, L. G. (2007) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2.2.141 · Cited by 2 · see citing works
Effect of Depot Medroxyprogesterone Acetate (DMPA) on Bone Mineral Density in Women of Reproductive Age
Gai, L., Zhang, J.-L., ZHANG, H.-Z., Gai, P., & Yong-hong, L. I. U. (2009) · Chin J Reprod Contracep · doi:10.1016/s1001-7844(09)60007-9 · Cited by 1 · see citing works
Contraception in Wisconsin: a review.
Schrager, S., Paddock, E., Dalby, J., & Knudsen, L. M. (2010) · PubMed · Cited by 1 · see citing works
Depotgestagene zur Kontrazeption bei der FrauGemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e.V. und des Berufsverbands der Frauenärzte (BVF) e. V.
Rabe, T., Ludwig, M. Z., Merkle, E., Hj, A., Kj, B., Hadji, P., Ao, M., Merki, G., Egarter, C., König, K., et al. (2013) · Journal für Reproduktionsmedizin und Endokrinologie · Cited by 1 · see citing works
ENDOMETRİOZİSE BAĞLI AĞRI TEDAVİSİNDE LEVONORGESTREL SALGILAYAN RAHİM İÇİ ARAÇ SİSTEMİ (LNG-RİA) VE NAPROKSEN SODYUM ETKİNLİĞİ KARŞILAŞTIRILMASI
Arslan, Ş. T., Börekçi, B., & Yılmaz, E. P. T. (2016) · Mustafa Kemal Üniversitesi Tıp Dergisi · doi:10.17944/mkutfd.287836 · Cited by 1 · see citing works
Hormonal Contraception
Hickey, M., & Kaunitz, A. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00018-3 · Cited by 1 · see citing works
Osteoporosis in childhood and adolescence
Nasomyont, N., & Gordon, C. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00037-x · Cited by 1 · see citing works
Bone Health and Hormonal Contraception
Dragoman, M. V., Kaunitz, A. M., & McClung, M. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2341-0_16 · Cited by 1 · see citing works
Hormonal contraception
Kaneshiro, B., & Edelman, A. B. (2011) · doi:10.1093/med/9780199235292.003.0817 · Cited by 1 · see citing works
Contraception hormonale
Serfaty, D. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-70921-0.00006-1 · Cited by 1 · see citing works
Bone mineral density and use of depot medroxyprogesterone acetate (DMPA), norethisterone enanthate (NET-EN) and combined oral contraceptives
Beksinska, M. E. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1 · see citing works
Steroidal contraceptives and bone fractures in women: evidence from observational studies
Lopez, L. M., Chen, M., Curtis, K. M., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009849 · Cited by 1 · see citing works
Adolescents with Medical Illness
Janiak, E., & Bartz, D. (2014) · Springer eBooks · doi:10.1007/978-1-4614-6579-9_9
Efeitos do sistema intra-uterino de Levonorgestrel sobre marcadores de risco cardiovascular de pacientes com endometriose: estudo comparativo com o análogo do GnRH
Ferreira, R. A. (2009) · doi:10.11606/t.17.2009.tde-26092013-165121
Contraception des cas particuliers
Serfaty, D. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-70921-0.00013-9
Actualización en anticoncepción en la adolescencia
Lara‐Torre, E. (2009) · Clínicas obstétricas y ginecológicas de Norteamérica · doi:10.1016/s1885-9070(09)36007-2
Variação da densidade mineral óssea no puerpério segundo amamentação, amenorréia, índice de massa corpórea e uso de método anticoncepcional
Costa, M. L. (2011) · doi:10.47749/t/unicamp.2011.802882
Avaliação da densidade mineral ossea em mulheres na pós-menopausa ex-usuarias do contraceptivo medroxiprogesterona de deposito
Sanches, L. C. (2008) · doi:10.47749/t/unicamp.2008.435535
Progestogen-Only Contraception: Unlimited Use Remains Appropriate
Rebar, R. W. (2006) · Journal watch · doi:10.1056/jw200607130000004
Body composition in long-term users of depot medroxyprogesterone acetate
Modesto, W., Orlandi, L. T., Bahamondes, M. V., et al. (2016) · Evidence Based Women s Health Journal · doi:10.1097/01.ebx.0000488796.09762.a6
Гормональная контрацепция и костная ткань
Grigoryeva, N. V. (2022) · PAIN JOINTS SPINE · doi:10.22141/2224-1507.1.9.2013.81980

Hormonal Contraceptive Continuation and Switching in South Africa
Smit, J. A., & Beksinska, M. E. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31827e818a · Cited by 22 · see citing works
Research on hormonal contraception and HIV
Cates, W. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60097-0 · Cited by 20 · see citing works
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
MORRISON, C. S., Chen, P., Kwok, C., Richardson, B. A., Chipato, T., Mugerwa, R. D., Byamugisha, J. K., PADIAN, N. S., Celentano, D. D., & Salata, R. A. (2010) · AIDS · doi:10.1097/qad.0b013e32833a2537 · Cited by 139 · see citing works
Prospective analysis of weight changes in adolescent females initiating depot medroxyprogesterone acetate (DMPA), oral contraceptive pills (OC), or no hormonal contraceptive method
Bonny, A. E., Camlin, K. L., Harvey, R., et al. (2003) · Journal of Adolescent Health · doi:10.1016/s1054-139x(02)00642-0 · Cited by 8 · see citing works
Breast cancer and depot-medroxyprogesterone acetate: A review
Chilvers, C. E. D. (1994) · Contraception · doi:10.1016/0010-7824(94)90039-6 · Cited by 10 · see citing works

Authors: d'Arcangues, C.
Venue: Contraception
Publisher: Elsevier BV
Published: 2006-05
Volume: 73
Issue: 5
Pages: 443-444
ISSN: 0010-7824 (ISSN-L)
DOI: 10.1016/j.contraception.2006.01.002
OpenAlex: W2134703699
Cited by: 109
References: 0
Citations by year: 2025: 2 · 2024: 1 · 2022: 2 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 6 · 2012: 6
FWCI: 13.66
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Contraception (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords: hormonal contraception, bone health, bone loss, depot medroxyprogesterone acetate, oral contraceptives, injectable contraceptives, contraceptive implants, osteoporosis risk, WHO consultation
MeSH terms: Adolescent, Adult, Contraceptive Agents, Female, Delayed-Action Preparations, Female, Humans, Middle Aged, World Health Organization, Bone Density, Medroxyprogesterone Acetate, Progesterone Congeners

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

WHO statement on hormonal contraception and bone health

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cited by

Related

Record

About these checks